Clinical Trial Update: Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy [Phase 2]

View source ↗

Summary

Phase II study of E7389 (eribulin, Halaven), a halichondrin B analogue, in patients with advanced non-small cell lung cancer who progressed after platinum-based…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Halaven (eribulin)

Snippet

Sponsor: Eisai Inc. | Conditions: Non-Small-Cell Lung Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-01-31